427 related articles for article (PubMed ID: 33243123)
1. Computational and Experimental Approaches to Investigate Lipid Nanoparticles as Drug and Gene Delivery Systems.
Chan C; Du S; Dong Y; Cheng X
Curr Top Med Chem; 2021; 21(2):92-114. PubMed ID: 33243123
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
[TBL] [Abstract][Full Text] [Related]
3. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
Qiu M; Li Y; Bloomer H; Xu Q
Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
[TBL] [Abstract][Full Text] [Related]
4. Arrayed CRISPR Screening Identifies Novel Targets That Enhance the Productive Delivery of mRNA by MC3-Based Lipid Nanoparticles.
Ross-Thriepland D; Bornot A; Butler L; Desai A; Jaiswal H; Peel S; Hunter MR; Odunze U; Isherwood B; Gianni D
SLAS Discov; 2020 Jul; 25(6):605-617. PubMed ID: 32441189
[TBL] [Abstract][Full Text] [Related]
5. The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.
Francia V; Schiffelers RM; Cullis PR; Witzigmann D
Bioconjug Chem; 2020 Sep; 31(9):2046-2059. PubMed ID: 32786370
[TBL] [Abstract][Full Text] [Related]
6. A Direct Comparison of in Vitro and in Vivo Nucleic Acid Delivery Mediated by Hundreds of Nanoparticles Reveals a Weak Correlation.
Paunovska K; Sago CD; Monaco CM; Hudson WH; Castro MG; Rudoltz TG; Kalathoor S; Vanover DA; Santangelo PJ; Ahmed R; Bryksin AV; Dahlman JE
Nano Lett; 2018 Mar; 18(3):2148-2157. PubMed ID: 29489381
[TBL] [Abstract][Full Text] [Related]
7. Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems.
Maeki M; Kimura N; Sato Y; Harashima H; Tokeshi M
Adv Drug Deliv Rev; 2018 Mar; 128():84-100. PubMed ID: 29567396
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Ethanol on Lipid Nanoparticle Stabilization from a Molecular Dynamics Simulation Perspective.
Hardianto A; Muscifa ZS; Widayat W; Yusuf M; Subroto T
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375391
[TBL] [Abstract][Full Text] [Related]
9. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
Zhang J; Haas RM; Leone AM
Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
[TBL] [Abstract][Full Text] [Related]
10. Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.
Tenchov R; Bird R; Curtze AE; Zhou Q
ACS Nano; 2021 Nov; 15(11):16982-17015. PubMed ID: 34181394
[TBL] [Abstract][Full Text] [Related]
11. Lipid Nanoparticles for Delivery of Therapeutic RNA Oligonucleotides.
Moss KH; Popova P; Hadrup SR; Astakhova K; Taskova M
Mol Pharm; 2019 Jun; 16(6):2265-2277. PubMed ID: 31063396
[TBL] [Abstract][Full Text] [Related]
12. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
13. Lipid Nanoparticle (LNP) Chemistry Can Endow Unique
Johnson LT; Zhang D; Zhou K; Lee SM; Liu S; Dilliard SA; Farbiak L; Chatterjee S; Lin YH; Siegwart DJ
Mol Pharm; 2022 Nov; 19(11):3973-3986. PubMed ID: 36154076
[TBL] [Abstract][Full Text] [Related]
14. A Combinatorial Library of Lipid Nanoparticles for Cell Type-Specific mRNA Delivery.
Naidu GS; Yong SB; Ramishetti S; Rampado R; Sharma P; Ezra A; Goldsmith M; Hazan-Halevy I; Chatterjee S; Aitha A; Peer D
Adv Sci (Weinh); 2023 Jul; 10(19):e2301929. PubMed ID: 37092557
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics.
Maier MA; Jayaraman M; Matsuda S; Liu J; Barros S; Querbes W; Tam YK; Ansell SM; Kumar V; Qin J; Zhang X; Wang Q; Panesar S; Hutabarat R; Carioto M; Hettinger J; Kandasamy P; Butler D; Rajeev KG; Pang B; Charisse K; Fitzgerald K; Mui BL; Du X; Cullis P; Madden TD; Hope MJ; Manoharan M; Akinc A
Mol Ther; 2013 Aug; 21(8):1570-8. PubMed ID: 23799535
[TBL] [Abstract][Full Text] [Related]
16. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.
Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M
ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806
[TBL] [Abstract][Full Text] [Related]
17. Delivery of RNAi therapeutics: work in progress.
Miller AD
Expert Rev Med Devices; 2013 Nov; 10(6):781-811. PubMed ID: 24195461
[TBL] [Abstract][Full Text] [Related]
18. Multiphysics-Informed Pharmacokinetic Modeling of Systemic Exposure of Intramuscularly Injected LNPs.
Di J; Wu K; Hou P; Corpstein CD; Xu Y; Li T
Mol Pharm; 2023 Dec; 20(12):6162-6168. PubMed ID: 37919256
[TBL] [Abstract][Full Text] [Related]
19. Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA.
Kulkarni JA; Myhre JL; Chen S; Tam YYC; Danescu A; Richman JM; Cullis PR
Nanomedicine; 2017 May; 13(4):1377-1387. PubMed ID: 28038954
[TBL] [Abstract][Full Text] [Related]
20. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
Wang C; Zhang Y; Dong Y
Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
